TMEM150C

Chr 4

transmembrane protein 150C

Also known as: TTN3

This gene encodes a transmembrane protein that forms a mechanosensitive ion channel activated by mechanical stimuli, functioning as a nonselective cationic channel with high calcium permeability in dorsal root ganglion neurons and contributing to proprioception, touch, and pain sensation. Mutations cause autosomal recessive intellectual disability with neurological and behavioral abnormalities. The gene shows low constraint against loss-of-function variants, consistent with a recessive inheritance pattern.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
37
P/LP submissions
0%
P/LP missense
0.87
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryTMEM150C
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 28 VUS of 71 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.87LOEUF
pLI 0.013
Z-score 1.90
OE 0.41 (0.210.87)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.52Z-score
OE missense 0.63 (0.530.76)
86 obs / 136.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.41 (0.210.87)
00.351.4
Missense OE0.63 (0.530.76)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 5 / 12.1Missense obs/exp: 86 / 136.0Syn Z: -0.05
DN
0.6648th %ile
GOF
0.75top 25%
LOF
0.2092th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

71 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic3
VUS28
Likely Benign1
34
Pathogenic
3
Likely Pathogenic
28
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
34
0
34
Likely Pathogenic
0
0
3
0
3
VUS
0
23
5
0
28
Likely Benign
0
0
1
0
1
Benign
0
0
0
0
0
Total02343066

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TMEM150C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗